Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00186472 · ClinicalTrials.gov registry record · NA

Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)

A NA study of Depression and Anxiety, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
1
Study location

NCT00186472 is a NA study of Depression and Anxiety that has completed, run by Stanford University. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00186472, a NA study of Depression and Anxiety, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
1
Study location

Study Summary

Infants born premature face numerous medical problems, causing significant anxiety for their parents. Parents experience a range of negative emotions including concern for the health and well being of their fragile infant, guilt, and disappointment. Research has indicated that having an infant in the Neonatal Intensive Care Unit (NICU) is highly stressful for parents and multiple studies have demonstrated that parents can develop significant psychological reactions to this experience. Specifically, many parents develop clinically significant anxiety disorders such as acute stress disorder (ASD) and posttraumatic stress disorder (PTSD). This not only impacts the mental well-being of the parents, but also can lead to problems with the parent-infant relationship, and, in turn, negatively impact the infant and the family as a whole. Despite the reported negative effects parents experience due to the stress of having an infant on the NICU, surprisingly little research has examined how to reduce parents' symptoms of anxiety. Because parents play an essential role in the care of their infant after discharge from the NICU, treating the parent's emotional distress is highly important. The purpose of this study is to examine the efficacy of a cognitive-behaviorally based intervention in reducing parents' symptoms of anxiety associated with having an infant on the NICU. This treatment is modeled after treatments that have proven effective with parents of children with other types of medical problems, for example, parents of children with cancer. It is the hope of the investigators that this intervention will effectively reduce symptoms of anxiety of NICU parents as well as the likelihood of developing subsequent psychological disorders.

Interventions

  • BEHAVIORAL Brief Cognitive Behavioral Treatment

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00186472

The ClinicalTrials.gov registry entry for NCT00186472 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Brief Cognitive Behavioral Treatment is the first listed.

NCT00186472 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00186472 about?

NCT00186472 is a clinical study titled "Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)". Infants born premature face numerous medical problems, causing significant anxiety for their parents. Parents experience a range of negative emotions including concern for the health and well being of their fragile infant, guilt, and disappointment. Research has indicated that having an infant in th...

What is the current status of trial NCT00186472?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00186472 study?

This clinical trial studies the following conditions: Depression, Anxiety, Posttraumatic Stress Disorder, Acute Stress Disorder.

What interventions are being tested in trial NCT00186472?

The interventions under investigation include: Brief Cognitive Behavioral Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00186472?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00186472 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.